OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 4

Data from combined, up to 2021-03-17.

Vaccinated at 2021-03-17 (%) Vaccinated at 2021-03-17 (n) Population Vaccinated at 2021-03-10 (%) Vaccinated in past week (%)
Overall - 55.3% 2,593,864 4,690,203 54.3% 1.0%
Sex Female 54.7% 1,379,987 2,523,549 53.6% 1.1%
Male 56.0% 1,213,877 2,166,654 55.1% 0.9%
Ethnicity White - British 58.7% 1,503,110 2,561,699 58.0% 0.6%
White - Irish 52.1% 14,644 28,098 51.5% 0.6%
White - Any other White background 42.3% 61,831 146,111 41.0% 1.3%
Mixed - White and Black Caribbean 37.2% 4,403 11,830 35.6% 1.7%
Mixed - White and Black African 38.0% 4,627 12,180 35.3% 2.7%
Mixed - White and Asian 45.4% 3,465 7,637 43.3% 2.1%
Mixed - Any other mixed background 40.6% 6,279 15,470 38.8% 1.8%
Asian or Asian British - Indian 48.6% 59,290 121,926 46.5% 2.2%
Asian or Asian British - Pakistani 42.5% 41,615 97,874 38.6% 3.9%
Asian or Asian British - Bangladeshi 51.6% 25,641 49,658 46.9% 4.7%
Asian or Asian British - Any other Asian background 44.6% 28,735 64,484 42.2% 2.3%
Black or Black British - Caribbean 34.8% 14,917 42,903 32.8% 2.0%
Black or Black British - African 36.1% 37,541 103,908 33.2% 3.0%
Black or Black British - Any other Black background 34.2% 6,454 18,858 31.8% 2.4%
Other ethnic groups - Chinese 45.5% 6,356 13,958 43.9% 1.6%
Other ethnic groups - Any other ethnic group 40.6% 15,911 39,158 38.4% 2.3%
Patients with any other ethnicity code 56.2% 349,580 621,894 55.3% 0.9%
Ethnicity not stated 55.8% 15,911 28,518 54.8% 1.0%
Ethnicity not recorded 55.9% 393,428 703,941 55.0% 0.9%
Ethnicity (broad categories) White 57.7% 1,579,599 2,735,929 57.1% 0.7%
Mixed 39.9% 18,802 47,131 37.8% 2.1%
South Asian 46.5% 155,309 333,956 43.4% 3.1%
Black 35.6% 58,926 165,683 32.9% 2.6%
Other 41.9% 22,281 53,116 39.9% 2.1%
Unknown 56.0% 758,926 1,354,360 55.1% 0.9%
Index of Multiple Deprivation 1 (most deprived) 50.4% 499,079 989,849 48.6% 1.9%
2 52.9% 500,878 945,966 51.6% 1.3%
3 56.4% 526,085 933,114 55.6% 0.8%
4 58.0% 523,096 902,132 57.4% 0.6%
5 (least deprived) 59.4% 521,038 876,498 59.0% 0.4%
Unknown 55.5% 23,653 42,623 54.4% 1.1%
Clinical Risk Groups Patients in Any Clinical Risk Group 54.4% 1,635,508 3,009,034 53.0% 1.3%
Patients with Immunosuppression 54.1% 234,822 434,063 53.3% 0.8%
Patients with CKD 57.6% 236,873 411,054 57.0% 0.6%
Patients who have Chronic Respiratory Disease 57.8% 340,627 588,854 57.2% 0.7%
Patients with Diabetes 51.2% 700,322 1,367,464 49.0% 2.2%
Patients with Chronic Liver disease 54.8% 116,109 211,890 53.4% 1.4%
Patients with CNS Disease (including Stroke/TIA) 57.8% 238,672 412,881 56.9% 0.9%
Patients with Chronic heart disease 58.3% 545,930 936,236 57.7% 0.7%
Patients with Asplenia or Dysfunction of the Spleen 51.3% 42,504 82,887 50.6% 0.7%
Patients with Wider Learning Disability 54.0% 30,373 56,259 51.9% 2.0%
Patients with Severe Mental Health 51.9% 40,579 78,183 49.7% 2.2%
Other Groups Patients who are shielding (High Risk from COVID-19) 50.7% 1,158,122 2,282,994 48.9% 1.8%
Patients with Morbid Obesity 53.0% 176,820 333,921 51.0% 1.9%
Patients who are pregnant 22.5% 6,433 28,588 19.7% 2.8%